Mubadala Investment-backed M42 invests in Juvenescence

Juvenescence is a clinical-stage AI-enabled biotech company developing novel medicines.

16 April 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.